IU-1
CAS No. 314245-33-5
IU-1( USP14 inhibitor IU1 )
Catalog No. M14014 CAS No. 314245-33-5
IU-1 (USP14 inhibitor IU1) is a specific, small molecule inhibitor of deubiquitinating enzyme USP14 with IC50 of 4-5 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 49 | In Stock |
|
| 10MG | 68 | In Stock |
|
| 25MG | 131 | In Stock |
|
| 50MG | 227 | In Stock |
|
| 100MG | 403 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIU-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionIU-1 (USP14 inhibitor IU1) is a specific, small molecule inhibitor of deubiquitinating enzyme USP14 with IC50 of 4-5 uM.
-
DescriptionIU-1 (USP14 inhibitor IU1) is a specific, small molecule inhibitor of deubiquitinating enzyme USP14 with IC50 of 4-5 uM; displays no activity against other human eight DUBs (Uch37, Uch-L1/L3, USP7, etc.); enhances proteasomal degradation in vivo, attenuates cerebral ischemia/reperfusion-induced neuronal injury in mice; also inhibits Dengue virus replication.(In Vitro):Usp14, a proteasome-associated deubiquitinating enzyme, can inhibit the degradation of ubiquitin-protein conjugates, in vivo and in vitro. IU1inhibits the catalytic activity of proteasome associated Usp14 in vitro. The IC50 of IU1 for Usp14 is 4-5 μM. IU1 binds specifically to the activated form of Usp14. IU1 can potentially inhibit Usp14 by preventing its docking on the proteasome, but direct tests of this scenario proved negative. Usp14 inhibition is rapidly established upon addition of IU1 and rapidly reversed upon its removal. IU1 also promotes degradation of Sic1, a CDK inhibitor from S. cerevisiae.
-
In VitroUsp14, a proteasome-associated deubiquitinating enzyme, can inhibit the degradation of ubiquitin-protein conjugates, in vivo and in vitro. IU1 inhibits the catalytic activity of proteasome associated Usp14 in vitro. The IC50 of IU1 for Usp14 is 4-5 μM. IU1 binds specifically to the activated form of Usp14. IU1 can potentially inhibit Usp14 by preventing its docking on the proteasome, but direct tests of this scenario proved negative. Usp14 inhibition is rapidly established upon addition of IU1 and rapidly reversed upon its removal. IU1 also promotes degradation of Sic1, a CDK inhibitor from S. cerevisiae.
-
In Vivo——
-
SynonymsUSP14 inhibitor IU1
-
PathwayProteasome/Ubiquitin
-
TargetDUB
-
RecptorUSP14
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number314245-33-5
-
Formula Weight300.377
-
Molecular FormulaC18H21FN2O
-
Purity>98% (HPLC)
-
SolubilityDMSO: 30 mg/mL (100 mM); Ethanol: 15 mg/mL (50 mM) ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESCC1=CC(C(CN2CCCC2)=O)=C(C)N1C3=CC=C(F)C=C3
-
Chemical Name1-[1-(4-fluorophenyl)-2,5-dimethylpyrrol-3-yl]-2-pyrrolidin-1-ylethanone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lee BH, et al. Nature. 2010 Sep 9;467(7312):179-84.
2. Nag DK, et al. Virus Res. 2012 Apr;165(1):103-6.
3. Lahaie N, et al. J Biol Chem. 2016 Mar 25;291(13):7156-70.
4. Min JW, et al. J Neurochem. 2017 Mar;140(5):826-833.
molnova catalog
related products
-
EOAI3402143
EOAI3402143 (Deubiquitinase inhibitor G9, EOAI 3402143) is a novel covalent deubiquitinase Usp9x/Usp24 inhibitor.
-
HBX 41108
HBx 41108 is a non-competitive, reversible inhibitor of USP7 with an IC50 of 424nM. HBx 41108 inhibited deubiquitination of p53 mediated by USP7 in a dose-dependent manner with an IC50 of 0.8μM.
-
GNE-6776
GNE-6776 is a novel potent, specific, non-covalent, orally bioavailable USP7 inhibitor with IC50 of 1.34 uM.
Cart
sales@molnova.com